| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 423 | 2022 |
| The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019 EM Alvarez, LM Force, R Xu, K Compton, D Lu, HJ Henrikson, ... The Lancet Oncology 23 (1), 27-52, 2022 | 125 | 2022 |
| Internet addiction and sleep quality among medical students during the COVID-19 pandemic: A multinational cross-sectional survey MJ Tahir, NI Malik, I Ullah, HR Khan, S Perveen, R Ramalho, AR Siddiqi, ... PloS one 16 (11), e0259594, 2021 | 94 | 2021 |
| Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021 GBD 2021 Anaemia Collaborators The Lancet Haematology 10 (9), e713-e734, 2023 | 62 | 2023 |
| Efficacy and safety of recently approved drugs for sickle cell disease: a review of clinical trials MA Ali, A Ahmad, H Chaudry, W Aiman, S Aamir, MY Anwar, A Khan Experimental hematology 92, 11-18. e1, 2020 | 60 | 2020 |
| Thyroid storm B Pokhrel, W Aiman, K Bhusal | 38 | 2017 |
| Low grade gliomas W Aiman, DP Gasalberti, A Rayi | 22 | 2020 |
| Primary mediastinal B-cell lymphoma: a 2021 update on genetics, diagnosis, and novel therapeutics Z Ahmed, SS Afridi, Z Shahid, Z Zamani, S Rehman, W Aiman, M Khan, ... Clinical Lymphoma Myeloma and Leukemia 21 (11), e865-e875, 2021 | 19 | 2021 |
| StatPearls B Pokhrel, W Aiman, K Bhusal Treasure Island, FL: StatPearls Publishing, 2022 | 17 | 2022 |
| Efficacy and safety of pembrolizumab based therapies in triple-negative breast cancer: A systematic review of clinical trials MA Ali, W Aiman, SS Shah, M Hussain, R Kashyap Critical Reviews in Oncology/Hematology 157, 103197, 2021 | 9 | 2021 |
| Efficacy and tolerability of isocitrate dehydrogenase inhibitors in patients with acute myeloid leukemia: a systematic review of clinical trials W Aiman, MA Ali, MA Basit, Z Omar, M Suleman, M Hassan, T Jamil, ... Leukemia Research, 107077, 2023 | 8 | 2023 |
| Efficacy and safety of oral GnRh antagonists in patients with uterine fibroids: a systematic review R Niaz, M Saeed, H Khan, MA Ali, A Irshad, M Faiz, A Irshad, F Fatima, ... Journal of Obstetrics and Gynaecology Canada 44 (12), 1279-1288, 2022 | 7 | 2022 |
| MM-082 Addition of Daratumumab to Drug Regimens in the Treatment of Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Clinical Trials W Aiman, A Anwar, DI Satti, M Hamza, AM Perez, AA Khan, A Nepal, ... Clinical Lymphoma Myeloma and Leukemia 22, S405, 2022 | 5 | 2022 |
| Delays in breast cancer diagnosis at a tertiary care facility in karachi, Pakistan M Hussain, Z Hasan, MA Ali, Z Tapal, F Saeed, W Aiman J Ayub Med Coll Abbottabad 33 (2), 248-251, 2021 | 5 | 2021 |
| Safety and efficacy of tyrosine kinase inhibitors in immune thrombocytopenic purpura: a systematic review of clinical trials MA Ali, MY Anwar, W Aiman, G Dhanesar, Z Omar, M Hamza, M Zafar, ... Journal of Xenobiotics 13 (1), 29-41, 2023 | 4 | 2023 |
| Efficacy and toxicity of surufatinib in neuroendocrine tumors: A systematic review and meta‐analysis MA Ali, SS Shah, N Tahir, S Rehman, M Saeed, SF Bajwa, R Ali, W Aiman, ... Journal of Neuroendocrinology 34 (7), e13149, 2022 | 3 | 2022 |
| Current status of monoclonal antibodies-based therapies in castration-resistant prostate cancer: a systematic review and meta-analysis of clinical trials TA Tarrar, MY Anwar, MA Ali, M Saeed, S Rehman, SF Bajwa, T Ayub, ... Cureus 14 (3), 2022 | 3 | 2022 |
| Efficacy and Safety of RET-Specific Kinase Inhibitors in RET-Altered Cancers: A Systematic Review MA Ali, SS Shah, R Ali, SF Bajwa, S Rehman, A Anwar, MY Anwar, ... Cancer Investigation 41 (8), 739-749, 2023 | 2 | 2023 |
| Efficacy and safety of viral vector based gene therapy in patients with hemophilia a: a systematic review W Aiman, SH Kazmi, M Saeed, MI Khan, Z Omar, M Suleman, T Jamil, ... Blood 140 (Supplement 1), 12992-12993, 2022 | 2 | 2022 |
| Efficacy and safety of IDH inhibitors in AML: a systematic review of clinical trials MA Ali, S Fatima, A Nepal, H Khan, MK Bhatti, M Saeed, R Niaz, R Habib, ... Blood 140 (Supplement 1), 11763-11764, 2022 | 2 | 2022 |
Muhammad Ashar AliBeth Israel Deaconess Medical Center, Harvard Medical SchoolVerified email at bidmc.harvard.edu
